Segment Information (Tables)

9 Months Ended

Sep. 28, 2012

Segment Reporting, Measurement Disclosures [Abstract]

Segment results are shown below ($ in millions):



Sales
	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011
Test & Measurement	$	814.5	$	856.7	$	2,517.3	$	2,535.4
Environmental	754.4		734.6		2,212.9		2,133.2
Life Sciences & Diagnostics	1,518.1		1,567.4		4,647.4		2,898.8
Dental	488.9		492.6		1,452.4		1,460.8
Industrial Technologies	839.6		794.5		2,455.2		2,345.7
	$	4,415.5	$	4,445.8	$	13,285.2	$	11,373.9



Operating Profit
	Three Months Ended						Nine Months Ended
	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011
Test & Measurement	$	163.6		$	205.2		$	539.4		$	567.6
Environmental	162.4			158.5			456.6			445.8
Life Sciences & Diagnostics	185.6			52.1			599.4			177.0
Dental	76.0			71.5			206.5			176.0
Industrial Technologies	183.5			174.3			531.6			514.5
Equity method earnings of Apex joint venture	18.5			16.0			50.9			44.9
Other	(33.8		)	(34.4		)	(82.4		)	(87.8		)
	$	755.8		$	643.2		$	2,302.0		$	1,838.0

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details